All lobbying filings
INVIVYD, INC.
INVIVYD, INC. filed a Q3 report for INVIVYD, INC. on October 1, 2026.
Lobbying for INVIVYD, INC. · education and awareness related to COVID-19 therapeutics
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 1, 2026
Expenses
$60,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
6
Lobbying activity
2
Onshoring, Domestic manufacturing
Monoclonal Antibodies, Infectious diseases